Skip to main content

Advertisement

SpringerLink
Log in

Efficacy of erenumab 70 mg in chronic migraine: Vicenza experience

  • BRIEF COMMUNICATION
  • Published:
Neurological Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  1. Tepper SJ, MD DHC, Ashina M, Brandes JL, Friedman DI, Reuter U, Cheng S, Nilsen J, Leonardi DK, Lenz RA, Mikol DD (2019) Erenumab in chronic migraine with medication overuse. Subgroup analysis of a randomized trial. Neurology 92:e2309–e2320

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Headache Center - Neurology Department, San Bortolo Hospital, Viale Rodolfi n 37, 36100, Vicenza, Italy

    Caterina Disco, Giuseppe Billo, Antonella De Boni, Cristina De Luca & Francesco Perini

Authors
  1. Caterina Disco
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Giuseppe Billo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Antonella De Boni
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Cristina De Luca
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Francesco Perini
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Caterina Disco.

Ethics declarations

Conflict of interest

I certify that there is no actual or potential conflict of interest in relation to this article.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Disco, C., Billo, G., De Boni, A. et al. Efficacy of erenumab 70 mg in chronic migraine: Vicenza experience. Neurol Sci 41 (Suppl 2), 479–480 (2020). https://doi.org/10.1007/s10072-020-04665-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-020-04665-2

Search

Navigation